PJP (PJP) Stock Price & Analysis
PJP (PJP) fell 1.69% to USD 126.97 as of September 8, 2026 at 14:51 UTC, according to Nexqual real-time market data.
PJP last closed at USD 126.97; the session ranged USD 126.01–127.25 on volume of 10,033 shares. Market capitalization is —, with a 52-week range of USD 90.01–131.68 (PCX). Source: Nexqual, September 8, 2026 at 14:51 UTC.
Key Statistics (as of September 8, 2026 at 14:51 UTC)
| Price | USD 126.97 |
|---|---|
| Change | ▼ 1.69% (down) |
| Previous Close | USD 126.97 |
| Open | USD 126.97 |
| Day Range | USD 126.01 – 127.25 |
| 52-Week Range | USD 90.01 – 131.68 |
| Volume | 10,033 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (PJP)
Nexqual's technical model rates PJP "NEUTRAL" based on 3 bullish and 2 bearish signals across 127 daily candles, as of September 8, 2026 at 14:51 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 52.5 (neutral) |
| vs SMA50 | Above (USD 123.62) |
| MACD | 1.56 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PBE | Invesco Biotechnology & Genome | USD 95.25 | ▼ 3.52% |
| IHE | iShares U.S. Pharmaceutical ETF | USD 103.13 | ▼ 2.18% |
| XPH | State Street SPDR S&P Pharmaceu | USD 70.66 | ▼ 0.52% |
| PBJ | Invesco Food & Beverage ETF | USD 47.72 | ▼ 0.83% |
| FBT | First Trust Amex Biotech Index | USD 265.18 | ▼ 3.14% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 14:51 UTC. This page is informational and not investment advice.